Kelly Shi
Stock Analyst at Jefferies
(0.47)
# 3,043
Out of 4,412 analysts
18
Total ratings
16.67%
Success rate
-19.43%
Average return
Main Sectors:
Top Industries:
17 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TIL Instil Bio | Downgrades: Hold | $5 → $11 | $10.48 | +5.01% | 1 | Apr 12, 2024 | |
| PTCT PTC Therapeutics | Maintains: Buy | $33 → $35 | $32.14 | +8.90% | 2 | Mar 20, 2024 | |
| INCY Incyte | Initiates: Buy | $81 | $52.56 | +54.11% | 1 | Feb 23, 2024 | |
| AVBP ArriVent BioPharma | Initiates: Buy | $35 | $16.34 | +114.20% | 1 | Feb 20, 2024 | |
| CABA Cabaletta Bio | Initiates: Buy | $36 | $10.48 | +243.51% | 1 | Feb 5, 2024 | |
| ASND Ascendis Pharma | Initiates: Buy | $150 | $140.15 | +7.03% | 1 | Dec 20, 2023 | |
| CNTA Centessa Pharmaceuticals | Upgrades: Buy | $4 → $11 | $9.29 | +18.41% | 1 | Nov 15, 2023 | |
| BGNE BeiGene | Initiates: Buy | $287 | $156.53 | +83.35% | 1 | Aug 17, 2023 | |
| PROK ProKidney | Initiates: Buy | $15 | $2.30 | +552.17% | 1 | Dec 21, 2022 | |
| MLTX MoonLake Immunotherapeutics | Initiates: Buy | $16 | $41.77 | -61.70% | 1 | Nov 11, 2022 | |
| KYMR Kymera Therapeutics | Initiates: Buy | $40 | $34.66 | +15.41% | 1 | Aug 15, 2022 | |
| GLUE Monte Rosa Therapeutics | Initiates: Buy | $20 | $5.61 | +256.51% | 1 | Aug 15, 2022 | |
| IBRX ImmunityBio | Initiates: Buy | $8 | $8.99 | -11.01% | 1 | Aug 3, 2022 | |
| ACET Adicet Bio | Initiates: Buy | $27 | $1.59 | +1,598.11% | 1 | Mar 4, 2022 | |
| HCM HUTCHMED (China) | Initiates: Buy | n/a | $18.91 | - | 1 | Aug 3, 2021 | |
| CNTB Connect Biopharma Holdings | Initiates: Buy | n/a | $1.37 | - | 1 | Apr 13, 2021 | |
| ADAG Adagene | Initiates: Buy | n/a | $2.25 | - | 1 | Mar 8, 2021 |
Instil Bio
Apr 12, 2024
Downgrades: Hold
Price Target: $5 → $11
Current: $10.48
Upside: +5.01%
PTC Therapeutics
Mar 20, 2024
Maintains: Buy
Price Target: $33 → $35
Current: $32.14
Upside: +8.90%
Incyte
Feb 23, 2024
Initiates: Buy
Price Target: $81
Current: $52.56
Upside: +54.11%
ArriVent BioPharma
Feb 20, 2024
Initiates: Buy
Price Target: $35
Current: $16.34
Upside: +114.20%
Cabaletta Bio
Feb 5, 2024
Initiates: Buy
Price Target: $36
Current: $10.48
Upside: +243.51%
Ascendis Pharma
Dec 20, 2023
Initiates: Buy
Price Target: $150
Current: $140.15
Upside: +7.03%
Centessa Pharmaceuticals
Nov 15, 2023
Upgrades: Buy
Price Target: $4 → $11
Current: $9.29
Upside: +18.41%
BeiGene
Aug 17, 2023
Initiates: Buy
Price Target: $287
Current: $156.53
Upside: +83.35%
ProKidney
Dec 21, 2022
Initiates: Buy
Price Target: $15
Current: $2.30
Upside: +552.17%
MoonLake Immunotherapeutics
Nov 11, 2022
Initiates: Buy
Price Target: $16
Current: $41.77
Upside: -61.70%
Kymera Therapeutics
Aug 15, 2022
Initiates: Buy
Price Target: $40
Current: $34.66
Upside: +15.41%
Monte Rosa Therapeutics
Aug 15, 2022
Initiates: Buy
Price Target: $20
Current: $5.61
Upside: +256.51%
ImmunityBio
Aug 3, 2022
Initiates: Buy
Price Target: $8
Current: $8.99
Upside: -11.01%
Adicet Bio
Mar 4, 2022
Initiates: Buy
Price Target: $27
Current: $1.59
Upside: +1,598.11%
HUTCHMED (China)
Aug 3, 2021
Initiates: Buy
Price Target: n/a
Current: $18.91
Upside: -
Connect Biopharma Holdings
Apr 13, 2021
Initiates: Buy
Price Target: n/a
Current: $1.37
Upside: -
Adagene
Mar 8, 2021
Initiates: Buy
Price Target: n/a
Current: $2.25
Upside: -